Yiheng Capital Management’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.58M | Hold |
|
|||||
|
2025
Q1 | $6.39M | Sell |
|
|||||
|
2024
Q4 | $14.3M | Buy |
|
|||||
|
2024
Q3 | $17.5M | Sell |
|
|||||
|
2024
Q2 | $26.7M | Hold |
|
|||||
|
2024
Q1 | $23.6M | Hold |
|
|||||
|
2023
Q4 | $24.7M | Hold |
|
|||||
|
2023
Q3 | $23.7M | Hold |
|
|||||
|
2023
Q2 | $34M | Buy |
|
|||||
|
2023
Q1 | $23.4M | Hold |
|
|||||
|
2022
Q4 | $28.2M | Hold |
|
|||||
|
2022
Q3 | $31.1M | Hold |
|
|||||
|
2022
Q2 | $29.9M | Hold |
|
|||||
|
2022
Q1 | $32.6M | Buy |
|
|||||
|
2021
Q4 | $14.9M | Buy |
|